Search company, investor...

Total Raised

$47.22M

Investors Count

8

Deal Terms

1

Funding, Valuation & Revenue

6 Fundings

Prealize has raised $47.22M over 6 rounds.

Prealize's latest funding round was a Series C - II for $7M on November 21, 2023.

Prealize's valuation in September 2017 was $24.51M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/21/2023

Series C - II

$7M

$99M

0

FY undefined

1

12/15/2022

Series C

$99M

$99M

0

FY undefined

10

4/8/2019

Series B

$99M

$99M

0

FY undefined

10

3/26/2018

Debt

$99M

$99M

0

FY undefined

10

9/27/2017

Series A

$99M

$24.51M

0

FY undefined

10

Date

11/21/2023

12/15/2022

4/8/2019

3/26/2018

9/27/2017

Round

Series C - II

Series C

Series B

Debt

Series A

Amount

$7M

$99M

$99M

$99M

$99M

Investors

Valuation

$99M

$99M

$99M

$99M

$24.51M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

10

10

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Prealize Deal Terms

1 Deal Term

Prealize's deal structure is available for 1 funding round, including their Series A from September 27, 2017.

Round

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$99M

$99M

$99M

$99M

Prealize Investors

8 Investors

Prealize has 8 investors. Cardinal Partners invested in Prealize's Series C - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

9/27/2017

11/21/2023

4
Series A, Series B (2019), Series C (2022), Series C - II (2023)

John Clarke

Venture Capital

New Jersey

00/00/0000

00/00/0000

Kleiner Perkins Caufield & Byers

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

John Doerr

Subscribe to see more

Angel Investor (Individual)

00/00/0000

00/00/0000

Premera Blue Cross

Subscribe to see more

Corporation

Washington

00/00/0000

00/00/0000

Third Security

Subscribe to see more

Subscribe to see more

Venture Capital

Virginia

First funding

9/27/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

11/21/2023

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Kleiner Perkins Caufield & Byers

John Doerr

Premera Blue Cross

Third Security

Rounds

4
Series A, Series B (2019), Series C (2022), Series C - II (2023)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

John Clarke

Subscribe to see more

Type

Venture Capital

Venture Capital

Angel Investor (Individual)

Corporation

Venture Capital

Location

New Jersey

California

Washington

Virginia

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare Prealize to Competitors

ClosedLoop Logo
ClosedLoop

ClosedLoop operates as a healthcare data science platform. It enables providers, payers, and value-based care organizations to make accurate, explainable, and actionable predictions of individual-level health risks, outcomes, and costs. It was formerly known as Deep Health Technologies. The company was founded in 2017 and is based in Austin, Texas.

Medial EarlySign Logo
Medial EarlySign

Medial EarlySign is a company that focuses on the development of machine learning-based decision support tools in the healthcare industry. The company's main services include the creation of predictive models that can identify individuals who are more likely to have a serious condition based on the analysis of existing clinical data. These models provide actionable insights and enable healthcare organizations to offer proactive, personalized, and predictive care management. The company primarily sells to organizations across the healthcare continuum, including diagnostic and pharmaceutical companies, medical centers, and researchers. It was founded in 2013 and is based in Hod Hasharon, Israel.

E
Epic

Epic specializes in the development of software for healthcare organizations.

AKASA Logo
AKASA

AKASA operates as artificial intelligence (AI) powered automation company. It uses machine learning to provide health systems with a single solution for automating revenue cycle operations. It was founded in 2018 and is based in South San Francisco, California.

I
Invigorate

Invigorate is a company focused on providing solutions for autoimmune care in the healthcare sector. The company offers a mobile application that provides information and tools to manage autoimmune conditions, including features for self-assessment, personalized care plans, symptom tracking and monitoring, and peer support. Invigorate primarily serves individuals living with autoimmune disorders. It was founded in 2020 and is based in Barrington, Illinois.

FinThrive Logo
FinThrive

FinThrive is an independent patient-to-payment solutions company that provides all the technology, advisory expertise, services, analytics and education programs health care organizations need to thrive in the communities that they serve. The company was founded in 2016 and is based in Alpharetta, Georgia.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.